2m 2m 2m 2m 2m 2m 2m
Claritev (CTEV)
NYSE
$26.29-$2.05 (-7.23%)
Price as of Jun 03, 2026 6:17 PM EDT- $428.2MMarket Cap
- -24.61%1-Year Change
- Health Information ServicesIndustry
Claritev (CTEV)
$26.29-$2.05 (-7.23%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 965.4M +3.74% | 930.6M -3.21% | 961.5M -10.95% | 1.1B -3.39% | |
Cost of Revenue | 253.4M +5.85% | 239.4M +1.67% | 235.5M +15.37% | 204.1M +16.43% | |
Gross Profit | 712.0M +3.01% | 691.2M -4.80% | 726.1M -17.08% | 875.6M -7.08% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 343.8M -0.04% | 343.9M +0.35% | 342.7M +0.63% | 340.5M +0.10% | |
Total Operating Expenses | 936.6M -59.64% | 2.3B +190.24% | 799.5M -44.57% | 1.4B +97.20% | |
Operating Profit | 28.8M +102.07% | -1.4B -958.08% | 162.0M +144.66% | -362.7M -193.94% | |
Interest Income | 1.6M -50.13% | 3.1M -61.98% | 8.2M +135.23% | 3.5M +11,566.67% | |
Interest Expense | N/A N/A | N/A N/A | -333.2M +9.82% | -303.4M +13.43% | |
Interest Income and Expense and Net | 1.6M -50.13% | 3.1M +100.96% | -325.0M +8.36% | -299.9M +12.14% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 333.2M +9.82% | 303.4M +13.43% | |
Income before Taxes | -373.1M -78.93% | -1.8B +1,553.94% | -107.1M -80.91% | -560.7M -513.98% | |
Income Taxes | -88.8M -28.90% | -124.9M +712.87% | -15.4M -226.25% | 12.2M -63.54% | |
Extraordinary Items | 0 -100.00% | 1.5B N/A | 0 -100.00% | 662.2M N/A | |
Net Income | -284.3M -82.73% | -1.6B +1,694.86% | -91.7M -83.99% | -572.9M -661.24% | |
Net Income from Continuing Operations Applicable to Common | -373.1M -78.93% | -1.8B +1,553.94% | -107.1M -80.91% | -560.7M -513.98% | |
Basic EPS and Net Income | -17.30 -83.03% | -101.92 +72,700.00% | -0.14 -84.44% | -0.90 -662.50% | |
Diluted EPS and Net Income | -17.30 -83.03% | -101.92 +72,700.00% | -0.14 -84.44% | -0.90 -662.50% | |
Basic Weighted Average Shares | 16.4M +1.78% | 16.1M -97.50% | 645.1M +0.97% | 638.9M -1.86% | |
Diluted Weighted Average Shares | 16.4M +1.78% | 16.1M -97.50% | 645.1M +0.97% | 638.9M -1.93% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 16.8M -0.20% | 16.8M -76.45% | 71.5M -78.58% | 334.0M +80.25% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 16.8M -0.20% | 16.8M -76.45% | 71.5M -78.58% | 334.0M +80.25% | |
Total Current Assets | 224.4M +27.83% | 175.5M -9.34% | 193.6M -56.67% | 446.7M +39.93% | |
Accumulated Depreciation | 1.1M -99.74% | 420.4M -1.17% | 425.4M +21.04% | 351.4M +23.52% | |
Property and Plant and Equipment and Net | 326.3M +11.51% | 292.6M +9.43% | 267.4M +14.86% | 232.8M +9.19% | |
Total Long-Term Assets | 33.3M -10.14% | 37.1M +70.38% | 21.8M -0.54% | 21.9M +125.70% | |
Total Assets | 4.9B -5.09% | 5.2B -26.04% | 7.0B -5.51% | 7.4B -10.33% | |
Income Taxes Payable | 197.6M -39.36% | 325.8M -37.54% | 521.7M -18.42% | 639.5M -15.17% | |
Total Short-Term Debt | 14.7M +10.87% | 13.3M 0.00% | 13.3M 0.00% | 13.3M 0.00% | |
Total Current Liabilities | 261.4M +22.25% | 213.8M +28.22% | 166.7M -5.18% | 175.8M +23.91% | |
Total Long-Term Debt | 4.6B +1.12% | 4.5B -0.51% | 4.5B -4.41% | 4.7B -2.81% | |
Total Long-Term Liabilities | 0 -100.00% | 3.6M -78.56% | 16.8M +59,839.29% | 28,000 -79.26% | |
Total Liabilities | 5.1B -0.22% | 5.1B -3.59% | 5.3B -5.82% | 5.6B -5.02% | |
Retained Earnings | -2.4B +13.25% | -2.1B +329.62% | -499.3M +43.56% | -347.8M -254.50% | |
Total Stockholders Equity | -173.9M -306.97% | 84.0M -95.08% | 1.7B -4.55% | 1.8B -23.63% | |
Total Shares Outstanding | 16.6M +2.25% | 16.2M -97.50% | 648.3M +1.43% | 639.2M +0.13% | |
Cash Flow | |||||
Cash from Operating Activities | 117.3M +9.02% | 107.6M -37.33% | 171.7M -53.88% | 372.4M -7.99% | |
Capital Expenditures | 129.6M +9.72% | 118.1M +8.52% | 108.9M +21.30% | 89.7M +6.08% | |
Cash from Investing Activities | -121.0M +2.45% | -118.1M -52.71% | -249.8M +139.16% | -104.4M -54.27% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.4M +105.72% | -41.3M -77.17% | -181.0M +56.38% | -115.7M +0.92% | |
Financials Ratio | |||||
Gross Margin | 73.75% -0.71% | 74.27% -1.64% | 75.51% -6.89% | 81.10% -3.82% | |
Operating Margin | 2.98% +101.99% | -149.35% -986.57% | 16.85% +150.15% | -33.60% -197.24% | |
Return on Assets | -5.66% -79.15% | -27.17% +2,023.74% | -1.28% -82.59% | -7.35% -694.10% | |
Return on Equity | 632.60% +444.61% | -183.57% +3,403.03% | -5.24% -81.09% | -27.71% -765.38% | |
Revenue Growth | 3.74% +216.32% | -3.21% -70.64% | -10.95% +222.92% | -3.39% -117.68% | |
Current Ratio | 0.86 +4.57% | 0.82 -29.29% | 1.16 -54.30% | 2.54 +12.93% | |
Cash Ratio | 0.06 -18.40% | 0.08 -81.64% | 0.43 -77.41% | 1.90 +45.46% | |
Debt-to-Equity Ratio | -26.31 -148.87% | 53.83 +1,923.87% | 2.66 +0.15% | 2.66 +27.27% | |
Debt-to-Assets Ratio | 0.94 +6.58% | 0.88 +34.53% | 0.65 +1.18% | 0.65 +8.38% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow